Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?

•The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiology 2020-05, Vol.75 (5), p.583-584
Hauptverfasser:	Spartalis, Michael, Iliopoulos, Dimitrios C., Spartalis, Eleftherios, Athanasiou, Antonios, Paschou, Stavroula A., Voudris, Vassilis, Siasos, Gerasimos
Format:	Artikel
Sprache:	eng
Schlagworte:	Death, Sudden, Cardiac - epidemiology Death, Sudden, Cardiac - etiology Death, Sudden, Cardiac - prevention & control Defibrillator Defibrillators, Implantable Heart failure Heart Failure - therapy Humans ICD Primary prevention Randomized Controlled Trials as Topic Sudden cardiac death
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy.
ISSN:	0914-5087 1876-4738
DOI:	10.1016/j.jjcc.2020.02.002